Objectives: To evaluate the knowledge and attitudes of older patients and their caregivers towards generic drugs. Design: Cross-sectional multicentre study. Methods: Older patients or their caregivers from 15 Italian departments of geriatrics, internal medicine, and rehabilitation completed a structured questionnaire to investigate their attitude towards generic drugs. Results: Among 312 patients (53.8 % females, mean age 79 years) and 163 caregivers (62.8 % females, mean age 62.8 years), caregivers reported knowing what a generic drug is more frequently than patients (96 % vs 84 %), and only 17 % in both groups declared to be well-informed on the subject. Patients were more likely than caregivers to believe that generic drugs take longer to become effective (22 % vs 12 %), are made with lower-quality substances (27 % vs 9 %), and are less effective (43 % vs 28 %) compared to brand-name drugs. Conclusions: Knowledge about generic drugs remains limited; educational and promotional initiatives are necessary to dispel misconceptions regarding generic drugs.
Knowledge and attitudes towards generic medicines: Point of view of older patients and their caregivers
Bursi, Marialucia;Petrucci, Chiara;Scaroni, Pierfederico;Trevisan, CaterinaUltimo
2025
Abstract
Objectives: To evaluate the knowledge and attitudes of older patients and their caregivers towards generic drugs. Design: Cross-sectional multicentre study. Methods: Older patients or their caregivers from 15 Italian departments of geriatrics, internal medicine, and rehabilitation completed a structured questionnaire to investigate their attitude towards generic drugs. Results: Among 312 patients (53.8 % females, mean age 79 years) and 163 caregivers (62.8 % females, mean age 62.8 years), caregivers reported knowing what a generic drug is more frequently than patients (96 % vs 84 %), and only 17 % in both groups declared to be well-informed on the subject. Patients were more likely than caregivers to believe that generic drugs take longer to become effective (22 % vs 12 %), are made with lower-quality substances (27 % vs 9 %), and are less effective (43 % vs 28 %) compared to brand-name drugs. Conclusions: Knowledge about generic drugs remains limited; educational and promotional initiatives are necessary to dispel misconceptions regarding generic drugs.| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S019745722500401X-main.pdf
solo gestori archivio
Descrizione: Full text editoriale
Tipologia:
Full text (versione editoriale)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
1.44 MB
Formato
Adobe PDF
|
1.44 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


